摘要: 刚刚是诺华在新泽西的工厂挂牌出售 现在是辉瑞因劳资纠纷，为了抵抗工人暴动，封锁印度工厂。哎…… Labor disputes lead Pfizer to lock workers out of plant in India Pfizer says it has tried, workers s ...
| 刚刚是诺华在新泽西的工厂挂牌出售 现在是辉瑞因劳资纠纷，为了抵抗工人暴动，封锁印度工厂。哎…… Labor disputes lead Pfizer to lock workers out of plant in India Pfizer says it has tried, workers say not hard enough August 4, 2014 | By Eric Palmer Labor issues at a Pfizer ($PFE) plant in Thane, India, have led the company to lock employees out of the facility after workers were said to have tried to stop production and threatened managers. The company did not say what has led to the problems, but workers told The Hindu BusinessLine that the 212 employees were frustrated after 6 years of discussions over salaries and medical coverage. According to a statement from Pfizer spokesperson Trupti Deepak Wagh, "We have engaged the workmen in many conversations in the past to maintain harmonious relations. Despite this, there continued to be incidents of indiscipline, threats to our management personnel as well as attempts to disrupt production lines. We place utmost emphasis on colleague safety and hence we have been forced to issue a lockout notice." Wagh said the lockout would not create any supply issues for the company, but that the company would not resume production until it got assurances from workers that the safety of "our colleagues will not be compromised in any manner." Labor disagreements are not uncommon in pharma. Last year, Teva Pharmaceutical Industries ($TEVA) backed down on proposed job cuts at plants there after labor leaders vowed to strike and the government jumped into the fray. In France, Sanofi ($SNY) has faced repeated labor actions over cuts it planned there. In 2012, Roche ($RHHBY) workers in Poland protested the company's use of contract employees. |
我们提供专业的服务， 从产品定位、机械的生产制造，我们 实力出众，只因我们更努力
公司生产的生物反应器及各种配套设备，可替代国外同类产品的垄断，并帮助企业节省生产成本，同时提供生产过程中各种技术支持。
我们一如既往地根据用户的需求、市场环境、企业状况等进行综合分析并提供真实可靠的解决方案，迄今为止服务上千家企业。
我们将致力于优质的技术服务确保每个机械设备的安全，用更成熟的方案解决每一个问题，为企业提供一站式服务。
